Lataa...
Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
INTRODUCTION: Factor Xa (fXa) inhibitor reversal for life-threatening bleeding is controversial due to a lack of high-quality evidence. The purpose of this study was to determine the hemostatic efficacy of four-factor prothrombin complex concentrate (4F-PCC) for the reversal of fXa inhibitors compar...
Tallennettuna:
| Julkaisussa: | West J Emerg Med |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Department of Emergency Medicine, University of California, Irvine School of Medicine
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7972353/ https://ncbi.nlm.nih.gov/pubmed/33856296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5811/westjem.2020.11.47931 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|